Warren
16th September 2005, 10:42 PM
MELVILLE, N.Y., Sept. 16 /PRNewswire/ -- Fougera, a specialty manufacturer
of dermatologic and ophthalmic pharmaceuticals, announced today that it has
received tentative FDA approval to introduce the first generic version of
Metronidazole Topical Gel USP 0.75%. The patent on the branded product by
Galderma expires on June 6, 2006...............See link below to read the rest
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-16-2005/0004109162&EDATE=
of dermatologic and ophthalmic pharmaceuticals, announced today that it has
received tentative FDA approval to introduce the first generic version of
Metronidazole Topical Gel USP 0.75%. The patent on the branded product by
Galderma expires on June 6, 2006...............See link below to read the rest
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/09-16-2005/0004109162&EDATE=